Pancreatic Neoplasms: all 3,311 studies

Page 17 of 34. Open to participants first (911), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of Prehabilitation as a Strategy to Minimize Surgical Risk in Pancreatic Surgery: Efficacy and Determining Factors.Status unknownNCT05489419Not applicable
• The PLATON NetworkTerminatedNCT05489250
• A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C MutationActive, not recruitingNCT05485974Phase 1
• Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic CancerCompletedNCT05483075Not applicable
• Nivolumab and All-trans Retinoic Acid for Pancreatic CancerStatus unknownNCT05482451Early Phase 1
• Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingNCT05481476Phase 2
• Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic CancerCompletedNCT05481463Phase 2
• GI Organ Tracking Via Balloon ApplicatorsWithdrawnNCT05471401Not applicable
• PAncreas Borderline and Locally Advanced Snapshot StudyStatus unknownNCT05470738
• Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity.CompletedNCT05470166Not applicable
• A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced CancerWithdrawnNCT05465590Early Phase 1
• Open Versus Laparoscopic Assisted PancreaticoduodenectomyStatus unknownNCT05463328Not applicable
• Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsActive, not recruitingNCT05462717Phase 1
• Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)CompletedNCT05461430
• Registry of Pancreatic Exocrine Insufficiency: Enzyme Dose Requirements and Outcomes in Pancreatic Exocrine Insufficiency Across AetiologiesCompletedNCT05450627
• 68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NETActive, not recruitingNCT05448157
• Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic CancerTerminatedNCT05442749Phase 2
• Early Supportive Care and Nutritional Support in Adults With Pancreatic CancerCompletedNCT05438927Not applicable
• The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic CancerStatus unknownNCT05438797Early Phase 1
• TCR-T Cell Therapy on Advanced Solid TumorsTerminatedNCT05438667Early Phase 1
• Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic CancerTerminatedNCT05435053Phase 2
• Relieving the Bile Ducts Prior to PancreatoduodenectomyCompletedNCT05434520
• Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CTCompletedNCT05430841Not applicable
• Switch Maintenance in PancreaticSuspendedNCT05419479Phase 1/2
• FOLFIRINOX + NIS793 in Pancreatic CancerTerminatedNCT05417386Phase 1
• Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant ChemotherapyWithdrawnNCT05415917Phase 2
• Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid TumorsCompletedNCT05415475Phase 1
• Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer PatientsCompletedNCT05411133Phase 1
• Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic CancerActive, not recruitingNCT05411094Phase 1
• Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic CancerStatus unknownNCT05400681
• Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic CancerStatus unknownNCT05399394Phase 2
• A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerActive, not recruitingNCT05394259Phase 1
• ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic TestingTerminatedNCT05380557
• Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic CancerWithdrawnNCT05379907
• Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer.WithdrawnNCT05360745Not applicable
• Redefining FOLFIORINOX in Older Pancreatic Cancer PatientsActive, not recruitingNCT05360732Phase 2
• A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic CancersCompletedNCT05360680Phase 1
• ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic CancerActive, not recruitingNCT05355298Phase 1/2
• Patient-derived Organoids Drug Screen in Pancreatic CancerCompletedNCT05351983Not applicable
• An Unusual Association Between Pancreatic Cancer and Purtscher-like RetinopathyCompletedNCT05350384
• A Prospective, Single-arm, Exploratory Clinical Study of Sintilimab Injection in Combination With Paclitaxel (Albumin-bound) and Gemcitabine in Translational Therapy in Patients With Unresectable Locally Advanced Pancreatic Cancer.Status unknownNCT05346146Phase 2
• Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.CompletedNCT05340569Not applicable
• A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal AdenocarcinomaActive, not recruitingNCT05336266Early Phase 1
• Study on Umorestat Hydrogen Sulfate Capsule in Patients With Locally Advanced/Metastatic Pancreatic CancerStatus unknownNCT05329597
• An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTCStatus unknownNCT05327582Phase 1/2
• Expression and Clinical Significance of IGHD in Pancreatic CancerStatus unknownNCT05327400
• Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image DataStatus unknownNCT05313854
• Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in MexicoCompletedNCT05305001
• Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic CancerStatus unknownNCT05298020Phase 2
• Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsCompletedNCT05292859
• Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic TechniquesStatus unknownNCT05289895
• Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System NeoplasmsStatus unknownNCT05287165Early Phase 1
• Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal CancerActive, not recruitingNCT05277766Phase 1
• Identify microRNAs in Cachexia in Pancreatic CarcinomaTerminatedNCT05275075
• Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines.CompletedNCT05266300
• Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer PatientsStatus unknownNCT05265663Not applicable
• Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic CancerStatus unknownNCT05262452Not applicable
• Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic NeoplasmsStatus unknownNCT05259384Not applicable
• A Phase II Clinical Trial of Fruquintinib as Third Line Treatment in Advanced Pancreatic CancerStatus unknownNCT05257122Phase 2
• Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical TrialStatus unknownNCT05253313Not applicable
• NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsTerminatedNCT05252390Phase 1
• Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas CancerWithdrawnNCT05251038Phase 1/2
• Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based ChemotherapyCompletedNCT05249075
• EUS-guided PORtal Vein Sampling for Circulating Tumor Cells in Pancreatic Cancer PatientsCompletedNCT05247164Not applicable
• Impact of Pancreatic Endoscopic Drainage on Exocrine Pancreatic Function in Unresectable Pancreatic CancerStatus unknownNCT05244174Not applicable
• P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsActive, not recruitingNCT05239143Phase 1
• SMMART Adaptive Clinical Treatment (ACT) TrialWithdrawnNCT05238831Early Phase 1
• A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-upStatus unknownNCT05237193
• Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and CarcinomasStatus unknownNCT05234450
• Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive ResultsCompletedNCT05226572
• Video Education With Result Dependent dIsclosureCompletedNCT05225428Not applicable
• Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary NeoplasmsCompletedNCT05225038Not applicable
• DDP ip Combined With AG in PDAC With Peritoneal MetastasisCompletedNCT05222204Phase 2
• Palliadelic Treatment to Reduce Psychological Distress in Persons With Advanced Gastrointestinal CancersCompletedNCT05220046Phase 1
• Pemigatinib in Subjects With Adenosquamous Carcinoma of the PancreasWithdrawnNCT05216120Phase 2
• Adavosertib and Gemcitabine in Advanced PancreaticWithdrawnNCT05212025Phase 2
• A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic CarcinomaTerminatedNCT05193604Phase 1
• Less Than 100 Hours Hospital Stay After Pancreatico-duodenectomy, RCTStatus unknownNCT05192044Not applicable
• Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic CancerCompletedNCT05191498Not applicable
• New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)TerminatedNCT05188586Not applicable
• EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes PatientsWithdrawnNCT05188573Not applicable
• Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic CancerStatus unknownNCT05187416
• Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the LiverCompletedNCT05182112Phase 1
• Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid TumorsWithdrawnNCT05181865Phase 1/2
• Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk FactorsStatus unknownNCT05181605Phase 2/3
• Intraoperative Radiation Therapy for Resectable Pancreatic CancerActive, not recruitingNCT05181488Not applicable
• The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic CancerStatus unknownNCT05178628Phase 3
• Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/BiopsyCompletedNCT05171517
• The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer PatientsStatus unknownNCT05168527Phase 2
• Pancreatico Enteric Anastomosis Post PancreaticoduodenectomyStatus unknownNCT05163977Not applicable
• A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR MutationsActive, not recruitingNCT05163028Phase 1
• First in Human Study of TORL-2-307-MAB in Participants With Advanced CancerActive, not recruitingNCT05159440Phase 1
• First in Human Study of TORL-2-307-ADC in Participants With Advanced CancerActive, not recruitingNCT05156866Phase 1
• A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
• CD276-targeted Chimeric Antigen Receptor T Cells in Treatment With Advanced Pancreatic CancerStatus unknownNCT05143151Phase 1/2
• Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data CenterStatus unknownNCT05141656
• Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic CancerActive, not recruitingNCT05141643Early Phase 1
• Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic AdenocarcinomaActive, not recruitingNCT05141513Phase 1
• First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic CancerActive, not recruitingNCT05141149Phase 1/2
• Effectiveness of Auricular Point Acupressure in Improving Quality of Life in Patients With Pancreatic CancerCompletedNCT05139199Not applicable

← Pancreatic Neoplasms overview